|4Jun 24, 4:34 PM ET

Northpond Ventures, LP 4

4 · Codex DNA, Inc. · Filed Jun 24, 2021

Insider Transaction Report

Form 4
Period: 2021-06-22
Transactions
  • Conversion

    Common Stock

    2021-06-22+9,375,3809,375,380 total(indirect: By: Northpond Ventures, LP)
  • Conversion

    Series A Preferred Stock

    2021-06-225,214,8510 total(indirect: By: Northpond Ventures, LP)
    Common Stock (5,241,851 underlying)
  • Purchase

    Common Stock

    2021-06-22$16.00/sh+468,750$7,500,0009,844,130 total(indirect: By: Northpond Ventures II, LP)
  • Conversion

    Series A-1 Preferred Stock

    2021-06-224,160,5290 total(indirect: By: Northpond Ventures, LP)
    Common Stock (4,160,529 underlying)
Footnotes (3)
  • [F1]Upon the closing of the initial public offering of Codex DNA, Inc. (the "Issuer"), each share of Class A Preferred Stock, par value $0.0001 per share (the "Series A Preferred Stock"), of the Issuer and each share of Class A-1 Preferred stock, par value $0.0001 per share of the Issuer (the "Series A-1 Preferred Stock") automatically converted on a one-for-one basis into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). The right to convert the Series A Preferred Stock and Series A-1 Preferred Stock into Common Stock had no expiration date.
  • [F2]Northpond Ventures GP, LLC ("Northpond GP LLC") is the general partner of Northpond Ventures, LP ("Northpond Fund"), and Michael P. Rubin is the managing member of Northpond GP LLC. As a result, each of Northpond GP LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund. Each of Northpond GP LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
  • [F3]Northpond Ventures GP II, LLC ("Northpond GP II LLC") is the general partner of Northpond Ventures II, LP ("Northpond Fund II"), and Michael P. Rubin is the managing member of Northpond GP II LLC. As a result, each of Northpond GP II LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond GP II LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION